Page last updated: 2024-08-18

cyclohexanol and Mood Disorders

cyclohexanol has been researched along with Mood Disorders in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's5 (55.56)29.6817
2010's3 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miller, MC1
Chugunov, AV; Gulieva, AE; Kamchatnov, PR; Kunel'skaia, NL; Umarova, KhIa1
Hardy-Baylé, MC; Passerieux, C1
Abrams, M; Cook, IA; Hunter, AM; Leuchter, AF1
Coplan, JD; Dwork, AJ; Fenton, AA; Fonseka, J; Glennon, E; Insanally, M; Park, S; Perera, TD; Persky, M; Sackeim, HA; Thirumangalakudi, L1
Bowers, L; Callaghan, P; Clark, N; Evers, C1
Bourgeois, JA; Brunberg, JA; Farzin, F; Hagerman, P; Hagerman, R; Hessl, D; Tassone, F; Zhang, L1
Chen, MC; Lane, HY; Lin, CH; Lin, CY; Lin, KS1
Brilmyer, M; Kant, R; Zeiler, D; Zimmer, B1

Reviews

1 review(s) available for cyclohexanol and Mood Disorders

ArticleYear
[Mood disorders].
    La Revue du praticien, 2008, Oct-31, Volume: 58, Issue:16

    Topics: Adolescent; Adult; Age Factors; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Diagnosis, Differential; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Hospitalization; Humans; Male; Mood Disorders; Personality Disorders; Pregnancy; Prognosis; Psychotherapy; Psychotropic Drugs; Recurrence; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Suicide; Time Factors; Venlafaxine Hydrochloride; Young Adult

2008

Trials

2 trial(s) available for cyclohexanol and Mood Disorders

ArticleYear
Brain functional changes (QEEG cordance) and worsening suicidal ideation and mood symptoms during antidepressant treatment.
    Acta psychiatrica Scandinavica, 2010, Volume: 122, Issue:6

    Topics: Adult; Analysis of Variance; Antidepressive Agents; Antidepressive Agents, Second-Generation; Brain; California; Causality; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Electroencephalography; Female; Fluoxetine; Humans; Male; Mood Disorders; Psychiatric Status Rating Scales; Severity of Illness Index; Suicide; Venlafaxine Hydrochloride

2010
Role of hippocampal neurogenesis in mnemonic segregation: implications for human mood disorders.
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2013, Volume: 14, Issue:8

    Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Cyclohexanols; Hippocampus; Male; Memory; Mood Disorders; Neurogenesis; Neurons; Placebos; Psychomotor Performance; Rats; Rats, Long-Evans; Stress, Psychological; Venlafaxine Hydrochloride

2013

Other Studies

6 other study(ies) available for cyclohexanol and Mood Disorders

ArticleYear
When depression doesn't lead with depression.
    JAMA psychiatry, 2013, Volume: 70, Issue:11

    Topics: Anger; Bipolar Disorder; Cyclohexanols; Depression; Depressive Disorder, Major; Emotions; Female; Fluoxetine; Humans; Irritable Mood; Male; Mood Disorders; Prefrontal Cortex; Venlafaxine Hydrochloride

2013
[Correction of affective disorders in patients with cochlear-vestibular disturbances of vascular origin].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2008, Volume: 108, Issue:4

    Topics: Adult; Aged; Analgesics; Antidepressive Agents, Second-Generation; Audiometry; Cochlear Diseases; Cyclohexanols; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mood Disorders; Psychometrics; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome; Ultrasonography, Doppler, Transcranial; Venlafaxine Hydrochloride; Vestibular Diseases

2008
Comparisons of psychotropic drug prescribing patterns in acute psychiatric wards across Europe.
    European journal of clinical pharmacology, 2004, Volume: 60, Issue:1

    Topics: Adult; Benzodiazepines; Biperiden; Chlorpromazine; Clozapine; Cyclohexanols; Diazepam; Drug Administration Schedule; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization Review; Europe; Female; Humans; Male; Mood Disorders; Olanzapine; Pharmacoepidemiology; Practice Patterns, Physicians'; Psychiatric Department, Hospital; Psychotropic Drugs; Schizophrenia; Time Factors; Venlafaxine Hydrochloride

2004
Dementia with mood symptoms in a fragile X premutation carrier with the fragile X-associated tremor/ataxia syndrome: clinical intervention with donepezil and venlafaxine.
    The Journal of neuropsychiatry and clinical neurosciences, 2006,Spring, Volume: 18, Issue:2

    Topics: Aged; Antidepressive Agents, Second-Generation; Ataxia; Atrophy; Brain; Cyclohexanols; Dementia; Dominance, Cerebral; Donepezil; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fragile X Mental Retardation Protein; Fragile X Syndrome; Genetic Carrier Screening; Humans; Image Processing, Computer-Assisted; Indans; Magnetic Resonance Imaging; Male; Mental Status Schedule; Mood Disorders; Neurologic Examination; Neuropsychological Tests; Nootropic Agents; Piperidines; Tremor; Trinucleotide Repeats; Venlafaxine Hydrochloride

2006
Time to rehospitalization in patients with major depressive disorder taking venlafaxine or fluoxetine.
    The Journal of clinical psychiatry, 2008, Volume: 69, Issue:1

    Topics: Adult; Combined Modality Therapy; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Female; Fluoxetine; Hospitalization; Humans; Interview, Psychological; Male; Mood Disorders; Patient Readmission; Prevalence; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires; Time Factors; Tobacco Use Disorder; Venlafaxine Hydrochloride

2008
Antidepressant efficacy and cardiovascular safety of venlafaxine in young vs old patients with comorbid medical disorders.
    International journal of psychiatry in medicine, 1997, Volume: 27, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Blood Pressure; Cardiovascular Diseases; Cerebrovascular Disorders; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Mood Disorders; Risk Factors; Venlafaxine Hydrochloride

1997